Evidence map›Paper›PMID 23343975›Full record

ReviewPharmacological reviews2013

Individual differences and social influences on the neurobehavioral pharmacology of abused drugs.

M T Bardo, J L Neisewander, T H Kelly

Abstract readReview
In one paragraph

Review in Pharmacological reviews, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 100 papers.

0numbers the graph read from it
0cells of the map it votes in
100citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

100 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Prefrontal cortex excitatory neurons show distinct response to heroin-associated cue and social stimulus after prolonged heroin abstinence in mice.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2025
    Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. The subjective value of social context in people who use cannabis.Experimental and clinical psychopharmacology · 2024
    Article
  10. Article
  11. Article
  12. Article
  13. Psychostimulants and social behaviors.Frontiers in pharmacology · 2024
    Review
  14. Article
  15. Article
  16. Article
  17. Rats choose alcohol over social reward in an operant choice procedure.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2023
    Article
  18. The intersection of empathy and addiction.Pharmacology, biochemistry, and behavior · 2023
    Review
  19. Neural circuits regulating prosocial behaviors.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2023
    Review
  20. Article

40 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

M T BardoDepartment of Psychology, University of Kentucky, BBSRB Room 447, 741 S. Limestone, Lexington, KY 40536-0509, USA. mbardo@uky.edu
J L Neisewander
T H Kelly

Funding

Training and Pilot CoreP50DA005312 · NIDA · UNIVERSITY OF KENTUCKY · PI BARDO, MICHAEL T · 1987 to 2016
$19.5M
NEURAL MECHANISMS OF DRUG SEEKING BEHAVIORR01DA011064 · NIDA · ARIZONA STATE UNIVERSITY-TEMPE CAMPUS · PI NEISEWANDER, JANET L · 1997 to 2018
$4.8M
D3 Receptor Compounds for the Treatment of Psychostimulant AbuseR01DA023957 · NIDA · UNIVERSITY OF NORTH TEXAS HLTH SCI CTR · PI LUEDTKE, ROBERT R · 2007 to 2017
$4.1M
NOVELTY, DOPAMINE AND RESPONSE TO AMPHETAMINER01DA012964 · NIDA · YAUPON THERAPEUTICS, INC. · PI BARDO, MICHAEL T · 2000 to 2013
$3.7M
KENTUCKY CENTER FOR CLINICAL AND TRANSLATIONAL SCIENCEUL1RR033173 · NCRR · UNIVERSITY OF KENTUCKY · PI KERN, PHILIP A · 2011 to 2011
$3.5M
NCRR NIH HHS UL1 RR033173NCRR NIH HHS UL1-RR033173NIDA NIH HHS DA023957NIDA NIH HHS DA11064NIDA NIH HHS P50 DA005312NIDA NIH HHS P50-DA05312NIDA NIH HHS R01 DA011064NIDA NIH HHS R01 DA012964NIDA NIH HHS R01 DA023957NIDA NIH HHS R01-DA12964
6 · The paper itself

Abstract

The interaction of drugs with biologic targets is a critical area of research, particularly for the development of medications to treat substance use disorders. In addition to understanding these drug-target interactions, however, there is a need to understand more fully the psychosocial influences that moderate these interactions. The first section of this review introduces some examples from human behavioral pharmacology that illustrate the clinical importance of this research. The second section covers preclinical evidence to characterize some of the key individual differences that alter drug sensitivity and abuse vulnerability, related primarily to differences in response to novelty and impulsivity. Evidence is presented to indicate that critical neuropharmacological mechanisms associated with these individual differences involve integrated neurocircuits underlying stress, reward, and behavioral inhibitory processes. The third section covers social influences on drug abuse vulnerability, including effects experienced during infancy, adolescence, and young adulthood, such as maternal separation, housing conditions, and social interactions (defeat, play, and social rank). Some of the same neurocircuits involved in individual differences also are altered by social influences, although the precise neurochemical and cellular mechanisms involved remain to be elucidated fully. Finally, some speculation is offered about the implications of this research for the prevention and treatment of substance abuse.

Indexed as

Illicit DrugsAnimalsHumansIndividualitySocial BehaviorSubstance-Related DisordersIllicit Drugs

Identifiers

PMID23343975
PMCPMC3565917

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.